Book
`
`7031 6
`
`Page
`
`37
`
`_.Project Page__.
`__
`Project No.
`InvestigatorCate BFcbrect
`
`Subject
`Filed in Book Number/Title
`
`
`Becca
`
`Th
`
`>
`RK
`L247 1STTacken
`7
`ERD Cc
`
`5 Sh
`
`n-
`2.60
`
`£4
`0
`
`f.
`
`1. E-tsfe - Naot
`2. KPa, Ett/Hd
`(._.
`3? >
`LW
`BO pr |
`22°
`Oo
`bo m\
`Aoly
`(\ E fohe A iA ASacit. Cat
`Sbucridl natura |
`foe We:
`aUps
`ez shh w
`Ba o~\ 20 / Nac |
`As
`A
`€foh
`he
`bau
`arctan
`Go
`SE US MW Carcuteahl
`Ke As (po\Erk Ab, feed oh Bu ABBEsalou
`
`
`AL}
`|
`©
`AO |. wal
`°
`\
`"s
`G uA
`a Phos, Siu
`iy
`ace
`>n\ Edt
`“
`solu bo WE ,Nddod
`Oo, Seh4u e+
`ry thea -
`chals ,
`‘Re murA Leal
`d viele t dé s
`pA
`Vo he
`A 4,770
`b.¥ $I solAs odd, A 6.75~{ U_ > g Mnaskdh MF
`rely ACS $0
`CAA fe IT
`ac ly { Phan ote eur
`wphnw
`Live
`EG2ot2 -
`pic.
`A
`£ Wawknia
`cB Lo A
`fad,
`b.
`AD ala
`-C shath. ALA ab {|
`“ErAnrl
`AsHA
`Qo,
`eh beled
`Lh,
`Keowee
`p
`hid - nattror| Ss Fo-
`:
`“SeeludA ow
`Lal
`Ll gahAe
`
`al
`
`Zan)
`
`\
`
`vibe
`
`Ab.4
`
`Lys
`
`~
`
`s&
`
`A AL,
`
`CY)
`
`elloe
`
`7
`Ma th
`Ke ATVee
`
`y
`& icba ye
`. cl
`8"
`ty
`(2 77 oo, a fa
`
`o b ( lo~ | UD. o
`
`4 as atarck
`
`igen
`
`ff
`
`f
`
`A
`
`shFleJ bownS M cal Fon I
`
`/
`
`Z
`
`oo
`
`Countersigned by
`
`Date
`Merck Exhibit 2129, PaBRclco, INC/MRL
`Mylan v. Merck, IPR20284805401/00}
`
`Merck Exhibit 2129, Page 152
`Mylan v. Merck, IPR2020-00040
`
`
`
`7031 6
`
`Page
`
`37
`
`_.Project Page__.
`__
`Project No.
`InvestigatorCate BFcbrect
`
`Subject
`Filed in Book Number/Title
`
`
`Becca
`
`Th
`
`>
`RK
`L247 1STTacken
`7
`ERD Cc
`
`5 Sh
`
`n-
`2.60
`
`£4
`0
`
`f.
`
`1. E-tsfe - Naot
`2. KPa, Ett/Hd
`(._.
`3? >
`LW
`BO pr |
`22°
`Oo
`bo m\
`Aoly
`(\ E fohe A iA ASacit. Cat
`Sbucridl natura |
`foe We:
`aUps
`ez shh w
`Ba o~\ 20 / Nac |
`As
`A
`€foh
`he
`bau
`arctan
`Go
`SE US MW Carcuteahl
`Ke As (po\Erk Ab, feed oh Bu ABBEsalou
`
`
`AL}
`|
`©
`AO |. wal
`°
`\
`"s
`G uA
`a Phos, Siu
`iy
`ace
`>n\ Edt
`“
`solu bo WE ,Nddod
`Oo, Seh4u e+
`ry thea -
`chals ,
`‘Re murA Leal
`d viele t dé s
`pA
`Vo he
`A 4,770
`b.¥ $I solAs odd, A 6.75~{ U_ > g Mnaskdh MF
`rely ACS $0
`CAA fe IT
`ac ly { Phan ote eur
`wphnw
`Live
`EG2ot2 -
`pic.
`A
`£ Wawknia
`cB Lo A
`fad,
`b.
`AD ala
`-C shath. ALA ab {|
`“ErAnrl
`AsHA
`Qo,
`eh beled
`Lh,
`Keowee
`p
`hid - nattror| Ss Fo-
`:
`“SeeludA ow
`Lal
`Ll gahAe
`
`al
`
`Zan)
`
`\
`
`vibe
`
`Ab.4
`
`Lys
`
`~
`
`s&
`
`A AL,
`
`CY)
`
`elloe
`
`7
`Ma th
`Ke ATVee
`
`y
`& icba ye
`. cl
`8"
`ty
`(2 77 oo, a fa
`
`o b ( lo~ | UD. o
`
`4 as atarck
`
`igen
`
`ff
`
`f
`
`A
`
`shFleJ bownS M cal Fon I
`
`/
`
`Z
`
`oo
`
`Countersigned by
`
`Date
`Merck Exhibit 2129, PaBRclco, INC/MRL
`Mylan v. Merck, IPR20284805401/00}
`
`Merck Exhibit 2129, Page 152
`Mylan v. Merck, IPR2020-00040
`
`
`
`Book
`
`7031 6
`
`Page
`
`38
`
`ProjectNo... Project Page
`
`\
`
`DO NOT BEGIN NEW EXPERIMENTSON THIS PAGE.
`
`
`
`{2d Reg 2cor -
`‘A
`ek £2
`
`oo TF
`
`bo
`
`the Sa
`NO pn
`Ee S2o0C |
`
`A
`
`As MS Oc f
`
`lh
`
`|illilllllilllllil|ll
`
`|lllllilllli|ll —
`
`Date
`Merck Exhibit 2129, Page 153
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 153
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`
`
`
`Ogput3eSaseqaauvjGt/‘pee]‘dol
`
`
`
`[w/Bwo;,yesayeudsoudGr/pze]‘woyj}0g
`
`
`
`
`
`Ge
`
`OE
`
`GE
`
`wdd
`
`Merck Exhibit 2129, Page 154
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 154
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\055-0101.D
`
`Sample Name: 70316-037
`
`0.5610g/50ml1 of saturated aq soln
`
`->
`
`Injection Date : 02/11/2002
`Sample Name
`> 70316-037
`
`@«: Operator
`
`: hansen
`
`9:14:02 AM
`
`Seq Line
`Vial No
`
`Inj. No.
`
`1
`:
`> 55
`
`:
`
`:
`
`1
`
`2 pl
`
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile,
`iml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`DAD1 C, Sig=210,8 Ref=360,100 (055-0101.D)
`
`0
`DAD1 E, Sig=268,16 Ref=360,100
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADI C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`{min]
`
`Type Width Height
`[min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`1
`5.34 VP
`2
`5.68 BB
`3
`4 13.04 BP
`
`5.463
`1.11
`0.077
`6.661
`1.34
`0.078
`0.081 734.72 3843.763
`0.430
`5.66
`183.469
`
`0.14
`0.16
`95.16
`4.54
`
`0.000000
`0.000000
`1.017704
`0.000000
`
`L-224,715
`
`Signal:
`
`2 DAD] E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`(min}
`
`Type Width Height
`{min}
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`5.68 BB
`1
`2 13.07 BP
`
`0.080
`0.404
`
`86.51
`2.76
`
`448.537
`84.451
`
`84.16
`15.84
`
`1.017704
`0.000000
`
`L-224,715
`
`HPLC0157
`
`02/11/2002
`
`9:27:28 AM
`
`*** End of Report ***
`
`.
`Page 1 of 1
`Merck Exhibit 2129, Page 155
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 155
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`
`
`
`9Seq9913STL'P7T
`
`ozpUTes
`
`T-YP00pzwu
`
`STajouwerzegeedywUsTIN)
`
`
`
`LEO-9TEOLIWYN
`
`TONDOUdZONdXa
`
`a
`
`
`
`71202002~97eG
`
`P2°Lout]
`
`
`
`qoedsWOYLSNI
`
`HTdNOwu¢qHaoud
`
`o¢bzD0udNd
`
`89LZEch
`
`ocdLNSATOS
`
`€STSN
`
`ZHL¥6°8LS9HMSésq
`
`2HPLL00c0saudla
`
`
`
`98SO8TPO6P2ov
`
`€°o?ou
`
`
`
`998n000°9LMd
`
`
`
`oasn00°9ad
`
`
`
`92850000000T"0Td40°O00€ab
`
`
`
`=assssssss=ssTSTJENNVYHD============
`
`
`
`ZHNVTO22S2’00PToads
`
`0S‘OT
`
`gP00°€-‘@Dasn
`HTTONN
`
`
`
`
`
`
`
`siajeuezegUOTRISTNbOY-74
`
`
`
`
`
`SsilajeweredHhutssao0r%q-7d
`
`ZHW£6S00S2007as
`
`p8eotIs
`
`ZH00°0710ass
`
`ouMaM
`
`00°Tod0gd
`
`wo00°07Xo
`
`SZajowezedoTdWNAT
`
`
`
`udd9¢1°6dtd
`
`ZHPPCO6ETd
`
`
`
`
`
`wdd9¢z°Q-d@d
`
`
`
`
`
`wo/wdd900S2'0WOWdd
`
`ZH90°00T-cd
`
`
`
`wo/ZH2S290°00TWOZH
`
`Merck Exhibit 2128, Page 156
`Mylan v. Merck, IPR2020-00040
`
`0°0
`
`S°0O°T
`
`S'T
`
`O°?
`
`S°e
`
`O°€
`
`cPego'¢
`
`6T0L*?
`
`0000°T|}
`
`P9Ph'?
`
`Oo
`a
`
`£888 "0
`0€99°T
`
`a
`
`SP0°Sg°S0°9g°9
`GL0°8G°80°6wdd3ao
`
`OQ
`CC
`
`T6960
`
`9976'0
`
`Merck Exhibit 2129, Page 156
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`
`
`
`Tw/SugtTesaqeydsoydSTL9227
`
`eeeeeee
`
`ee
`
`
`
`SzajewezegejeqJuezIND
`
`
`
`LEO-9TEOLGNWN
`
`TOND0UdTONdXa
`
`2HL¥6°8L59HMScsa9SN
`
`
`
`98SOBTP06P2ov
`
`C°0Fou
`
`
`
`ZH9LL002°0saudld
`
`
`
`99sn000°9LMa
`
`
`
`oesn00°9ad
`
`
`
`28S0000000T0Td10°O0€ad
`
`
`
`rARAITAUITA~a7ed
`
`StLouTL
`
`
`
`qoedsWOYLSNI
`
`HTdNOum¢GHd0ud
`
`o¢bzDoudnd
`
`B89LCEGL
`
`ocdLNAATOS
`
`
`
`msssssssssss5T3TSNNVHOsesssssss=ss=
`
`
`
`oesn0S'0TTd
`
`ZHNPT0Z2S7'00PTOSS
`
`aP00°€-Td
`
`HTTONN
`
`
`
`
`
`siajouezeguoT]TSTNboy-7d
`
`0°0
`
`50O°TS‘T
`
`4
`
`Ge
`
`€599'0
`
`98202
`
`ny
`
`Se
`
`g's0°9g°9
`
`Gb
`
`$°80°6wd
`
`Qa
`
`BLbP'T
`
`€LbS'0
`
`
`
`wo/udd90057°0WONdd
`
`
`
`w9/ZH2529000TWOZH
`
`ZH90°00T-cd
`
`Merck Exhibit
`Mylan v. Merck, |
`
`Page 157
`20-00040
`
`yerbaqut
`
`‘MS
`
`ZHW£6S00S2007ds
`
`pseorIS
`
`2H00°0a0ass
`
`ouMGM
`
`00°Tod0gD
`
`wo00°0FXO
`
`
`
`SlejeuezedjoTdYNdT
`
`
`
`wdd9S1°6ald
`
`2HDPCO6ETd
`
`
`
`
`
`wdd9$z°0-d@d
`
`
`
`
`
`szejeweredHutsse.0rg-74
`
`Merck Exhibit 2129, Page 157
`Mylan v. Merck, IPR2020-00040
`
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\060-0101.D
`
`Sample Name: 70316-035
`
`6.37g/50m1 of 146.86 ML and wash
`
`Injection Date
`Sample Name
`
`@::: Operator
`
`02/12/2002
`70316-035
`
`hansen
`
`3:04:29 PM
`
`Seq Line
`Vial No
`
`Inj. No.
`
`Inj. Vol
`C: \HPCHEM\HPLCO157\METHODS\715.M
`Method
`01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1lml/min
`10min 25/75 water/acn; 75/25 from 10 to 14
`waters cl8 symmetry, 250 nm
`
`min
`
`DAD1 C, Sig=210,8 Ref=360,100 (060-0101.D)
`
`BN
`uw
`—_
`wo
`4
`2
`eeee BoeA, he
`
`-
`
`> ©+
`
`~<
`
`ee
`
`4
`2
`0
`DAD1 E, Sig=268,16 Ref=360,100 (060-0101.D
`
`8
`
`
`
`)
`:
`‘ib
`:
`oO
`WERte ae PTa
`6
`8
`10
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`Signal
`01/14/2002
`1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADI1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`(min]
`
`Type Width Height
`{min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13.
`14
`15
`
`2.44 VB
`3.64 VB
`4.15 BV
`5.16 BV
`5.30 VB
`5.65 BV
`5.88 VV
`6.22 VB
`6.69 BV
`6.97 VV
`7.64 VV
`7.93 VV
`8.24 VV
`8.52 VV
`8.89 VV
`
`289.753
`73.72
`0.060
`713.782
`0.082 135.35
`59.210
`0.090
`9.93
`226.496
`0.086
`41.08
`19.388
`0.075
`4.00
`0.081 240.31 1259.296
`0.092 2.06e3 1.170e4
`0.122
`4.59
`40.838
`0.127
`1.17
`10.716
`0.122
`1.00
`8.968
`0.105
`16.41
`122.782
`0.091
`59.85
`373.427
`0.096
`97.68
`655.861
`0.106
`4.07
`30.668
`0.097
`15.34
`103.325
`
`1.64
`A.04
`0.33
`1.28
`0.11
`7.12
`66.19
`0.23
`0.06
`0.05
`0.69
`2.11
`3.71
`0.17
`0.58
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.331258
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`0.3%¥25
`
`HPLCO157
`
`02/12/2002
`
`3:17:48 PM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 158
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 158
`Mylan v. Merck, IPR2020-00040
`
`
`
`Print of window 38: Current Chromatogram(s)
`
`Current Chromatogram(s}
`DAD1 C, Sig=210,8 Ref=360,100 (U'\VAGILENTIHPLC0157\20020213\061-0101.D)
`
`mAU
`
`~T
`8
`6
`DAD1 E, Sig=268,16 Ref=360,100 (U:\AGILENT\HPLC0157\20020213\061-0101.D)
`2CO-
`
`HPLCO157 02/13/2002 8:33:02 AM hansen
`:
`
`Page 1 of l
`Merck Exhibit 2129, Page 159
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 159
`Mylan v. Merck, IPR2020-00040
`
`
`
`Book
`
`7031 6
`
`Page
`
`39
`
`Subject
`
`Project No. CéProject Page
`[3 FibQe2
`Restricted
`RE Confidentiat
`limited access
`i.
`
`Date
`
`Filed in Book Number/Title
`
`HOIyt
`
`L2245
`
`Fu
`334.
`R2G.0
`4H
` /d11F
`
`
`
`lwophlu
`
`042°
`
`
`
`2
`At ne
`Kensyintt',
`6h
`2D 0
`Airine tec A PABAN-Ww2z TWihce
`s
`YO
`(S_
`Metorek, de Hel
`2\th-lwo
`245
`IS.0
`ik
`EDC
`[2 (3) Bo
`[2
`WAM Went
`On
`AC
`‘| hee|Tevarekbh Se luwe a A N rad J salt ol.
`
`
`
`
`
`+, 6]o AANA EDc
`Ma sequmbillg
`]-30Arn,
`
`Benetton gle Ke 215K fdfbYe-l ho 4r~( Eton
`|
`ol 51 wee,
`drow SS 2s) Nocl.
`ndatrhdrA fear{
`¥,
`J-
`.
`6
`ht
`4g Vall
`A
`OfW
`Wn
`AoPSE SBC 12,
`by dle
`Sela Figen
`ClLHMm
`ub Ao??.. EH Complete
`Wei,
`olmbal Ass. Ae 34 We Oeku
`1 4 te
`uf E7L,-lf ue. Re dissoleA am BN EMMA
`tblA
` /soat Baek WeshA Uf
`4 Sal ERK. DAselud
`10
`ou ED)
`weasnt
`ho. phd
`pole lee
`
`tcl SeedA13, T9900 CoachLincs or cuceds
`
`WE:
`NE dd
`a
`slaw
`Seeych&
`we presat. These bok
`le edu supe Gt stil
`pathy
`ple eat b
`SC
`+> addacrut
`py)
`kk
`2
`oold ¢
`SC] holy
`
`X
`
`4
`
`whe
`
`
`
`:
`
`s
`
`Countersigned by
`
`Merck Exhibit 2129, Paggcl60co. incuA
`Mylan v. Merck, IPR202848768401/00}
`
`Date
`
`Merck Exhibit 2129, Page 160
`Mylan v. Merck, IPR2020-00040
`
`
`
`ook
`
`70316
`
`rece
`
`40
`
`Project No.
`
`Project Page
`
`
`
`DO NOT BEGIN NEW EXPERIMENTSON THIS PAGE.
`
`-
`
`he
`
`chi
`bos
`
`6c wc
`Thh perdles
`we
`
`athek ¢
`Flakes
`ISK b2ucl}
`Ze.
`ate |
`rad
`~o%
`h
`La
`tepru F
`SFsluny
`Pee mw a-3-\
`#
`tochecke Sony
`703 14-039
`Lat 4 foC
`35. S 1626-035. Chee
`he
`AL
`&
`7 Jona
`ec A + tourney
`solid
`Ll lr 1 © he
`fa sh.
`qs.
`(
`on I ~ Fe
`‘aur
`Phys Mus
`70216-0387
`-
`ChalA to
`iy -* ( bor
`g Fbacor - At,
`d
`whe
`like So
`Halpkd
`Bors
`40
`b OA TA:
`\
`¢
`ON
`( M4.
`deck.
`Aa Hl Br rales
`('
`A ‘ore Woe
`
`2 |th20e2—rualebrig Re dnl” FiGE.. > ued Lo tupicd
`Hole pede
`ere
`B59), min
`44 AZ) hn
`Mv
`(
`EST, kar.
`£
`C
`uy ce
`Ls
`5~ sf pf
`cfd
`a
`stydothys Murs
`J malls
`Sheer
`sursce
`de hod ON gs
`Lg EB ZF be
`
`te shp
`25n( Ethel
`‘(lxcd
`cosh A &/ Etc
`
`t
`
`f
`
`dip./4 cy F- sagt
`Frew
`Grn bt
`post
`
`|llIlIiilllMIil |ll
`
`|ll llllillIll ll —
`
`Date
`Merck Exhibit 2129, Page 161
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 161
`Mylan v. Merck, IPR2020-00040
`
`
`
`MERCK & CO., INC.
`R827-L 4/75 ,#
`“DATE
`
`Feb 14, OL
`
`SUBMITTED BY
`
`REQUEST FOR ANALYSIS:
`oTERGSROFOR BATCH #
`oriséss | ouses
`OWE 034
`
`SAMPLE DISPOSITION
`
`MOLECULAR WEIGHT
`
`PROJECT #
`
`EXT
`
`SEND REPORT TO ~
`
`AREA
`
`Qari STRUCTURE
`C-TT4HW pvwuspraty, tf—OZNSOST
`CUI AS mls
`OU30T&
`
`CHEMICAL NAME
`
`( JRETAIN ( JRETURN[ JOISCARD
`
`OTHER TESTS AND COMMENTS
`
`|[TITRATION
`wen
`DISC
`SOLUTION
`
`
`
`UV
`
`SPECIFIC
`RESIDUE
`ROTATION | ON
`
`
`
`
`IGNITION
`
`
`
`
`
`VPC iatnira}
`
`ALL
`MESH
`est ag
`
`TEST
`
`KARL
`TOTAL
`FISCHER ai SOLIDS
`
` HEAVY
`
`
`| ANALYSIS | PSA
`
`
`
`CHN
`
`RESULTS
`
`“DSC
`
`TG
`
`X- RAY
`
`TLC
`
`WRITE
`
`BELOW
`
`THIS
`
`BULK
`
`LINE
`
`
`
`Ox=O1150 ss
`(OX
`Avta%
`Chir
`
`=
`-
`sy)
`’
`-
`as
`onl
`(ores
`On
`~
`C- TUS maf ~ AG .o% “lo
`0O.41
`O.\\ %G
`
`Re
`
`aa.1b
`
`swur
`“nie
`
`=
`
`348 DL
`
`.
`
`7
`
`oer
`
`1
`
`.
`
`7}
`fj
`
`i
`
`.
`(o1ssse)
`Cru ns Maw qu.tt 4o
`
`min
`
`6.18%
`
`VRE LSVWUS
`
`:
`
`_OLISOSe_
`Area
`OT
`OMT
`0.86
`SIU
`Ud
`OA8t <7
`10
`oslo
`WAV
`o.yO%
`VAY
`ONVL
`t.3l
`Osun
`“= 449
`6 oS%
`AL
`fess
`bse
`yA
`(0°
`ose
`lve
`o.tst OwhD 1Oimap > 0.05 &
`1-33
`it
`00%
`W290
`oot
`PP LAB PROC #
`.
`ANALYST
`DATE
`
`mad
`dow ee vob.
`Eel Uo. 1a)z
`
`
`2.0\
`2.04
`
`O61 %
`Or 7 ly
`
`Merck Exhibit 2129, Page 162
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 162
`Mylan v. Merck, IPR2020-00040
`
`
`
`Hansen, Karl
`
`Dorwart, Jason G.
`Thursday, February 21, 2002 11:13 AM
`Hansen, Karl
`RE:
`
`rom:
`ent:
`To:
`Subject:
`
`RRT
`0.95
`0.97
`1.00
`
`Jason
`
`Area%
`0.17%
`0.11%
`99.67%
`
`soeeeOriginal Message-----
`From:
`Hansen, Karl
`Sent:
`Thursday, February 21, 2002 9:34 AM
`To:
`Dorwart, Jason G.
`Subject:
`RE:
`
`How was the chemical purity?
`
`soooOriginal Message-----
`From:
`Dorwart, Jason G.
`
`@ Thursday, February 21, 2002 9:30 AM
`
`0:
`Subject:
`
`Hansen, Karl
`
`Here are the chiral purity results for the Phosphate salt and ML's from NB#70316-039
`
`Solids = 96.02% major
`ML's = 94.22% major
`
`3.98%minor
`5.78% minor
`
`Jason
`
`Merck Exhibit 2129, Page 163
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 163
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLC0157\DATA\067-0101.D
`
`Sample Name: 70316-039
`
`aqueous washes
`
`->
`
`Injection Date : 02/14/2002
`Sample Name
`> 70316-039
`Acq Operator
`: hansen
`
`12:42:50 PM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC1lO4/Acetonitrile, 1lml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`:
`:
`:
`:
`
`1
`67
`1
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (067-0101.D)
`
`2
`0
`DAD1 E, Sig=268,16 Ref=360,100 (067-0101 D)
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`(min]
`
`Area
`(mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.06 BV
`1
`2.20 VV
`2
`2.27 VV
`3.
`2.51 VV
`4
`2.63 VV
`5
`3.19 VV
`6
`3.29 VV
`7
`3.64 VB
`8
`4.02 BV
`9
`5.67 BV
`10
`11°=«5.87 VV
`12
`6.12 VB
`13.
`7.01 BP
`14
`8.60 VB
`15
`9.39 BB
`
`463.151
`94.62
`0.081
`0.046 1.77e3 5194.654
`0.120 2.34e3 2.129e4
`0.176 2.0963 2.414e4
`0.095 1.02e3 5797.346
`0.079
`10.37
`56.353
`0.115
`12.32
`102.662
`0.086
`9.89
`57.430
`0.111
`1.45
`11.322
`0.076
`10.94
`54.555
`0.076
`2.17
`10.401
`0.088 318.25 1791.939
`0.104
`85.48
`613.774
`0.084
`6.19
`33.679
`0.105
`4.35
`33.252
`
`0.77
`8.63
`35.39
`40.12
`9.64
`0.09
`0.17
`0.10
`0.02
`0.09
`0.02
`2.98
`1.02
`0.06
`0.06
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.011273
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`02/14/2002
`
`12:56:00 PM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 164
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 164
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C:\HPCHEM\HPLCO157\DATA\067-0101.D
`RT
`Type Width Height
`Area
`Area
`([min]
`{(min]
`[mAU*s]
`%
`
`Amount
`mg/ml
`
`Sample Name: 70316-039
`Name
`
`9.90 PP
`16
`17 12.09 VB
`
`0.082
`0.078
`
`2.83
`99.20
`
`14.608
`496.372
`
`0.02
`0.83
`
`0.000000
`0.000000
`
`Signal:
`
`2 DAD1 E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.05 BV
`1
`0.00
`2
`7.01 BB
`3.
`4 12.09 BB
`
`0.072
`0.000
`0.104
`0.078
`
`4.51
`0.00
`4.85
`8.01
`
`21.712
`0.000
`34.697
`40.019
`
`22.52
`0.00
`35.98
`41.50
`
`0.000000
`0.011273
`0.000000
`0.000000
`
`L~-224,715
`
`*** End of Report ***
`
`HPLCO157
`
`02/14/2002
`
`12:56:00 PM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 165
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 165
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\068-0101.D
`
`Sample Name: 70316-039
`
`5.07g/50m1l of 50.00g ml and wash
`
`->
`
`Injection Date : 02/19/2002
`Sample Name
`: 70316-039
`Acq Operator
`: hansen
`
`10:46:47 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile,
`iml/min
`lOmin 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`:
`:
`:
`:
`
`1
`68
`1
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (068-0101.D)
`oO}
`6S
`
`vt
`oOKt
`8
`o +
`©N=—
`N o
`>
`3
`=
`o
`PEE$type
`
`DAD1 E, Sig=268,16 Ref=360,100 (068-0101 .D)
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADi C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13.
`14
`15
`
`0.47 BV
`0.68 VP
`2.61 BV
`2.94 VV
`3.14 VV
`4.01 VV
`4.45 VV
`4.75 VV
`4.97 VV
`5.37 VB
`0.00
`5.93 BV
`6.45 VV
`6.73 VV
`6.90 VV
`
`60.632
`8.68
`0.106
`28.938
`4.08
`0.107
`256.923
`33.82
`0.123
`82.116
`7.44
`0.149
`97.780
`9.65
`0.132
`683.647
`17.12
`0.496
`608.926
`67.86
`0.131
`89.556
`9.61
`0.133
`115.106
`9.37
`0.163
`0.089 1.5463 8643.102
`0.000
`0.00
`0.000
`0.282
`6.93
`154.725
`0.144
`8.21
`85.602
`0.116
`15.35
`128.594
`0.070
`4.66
`22.367
`
`0.50
`0.24
`2.13
`0.68
`0.81
`5.66
`5.04
`0.74
`0.95
`71.60
`0.00
`1.28
`0.71
`1.07
`0.19
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`02/19/2002
`
`10:59:38 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 166
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 166
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C:\HPCHEM\HPLCO157\DATA\068-0101.D
`RT
`Type Width Height
`Area
`Area
`{min}
`(min)
`[mAU*s]
`%
`
`Sample Name: 70316-039
`Name
`
`9.66 PV
`16
`9.96 VV
`17°
`18 10.09 VV
`19 10.18 VV
`20 10.37 VB
`21 10.89 BB
`22 11.89 VV
`23 12.07 VV
`24 12.16 VV
`25 12.44 VV
`26 12.67 VV
`27°12.91 VV
`28 13.12 VB
`
`0.161
`0.100
`0.077
`0.075
`0.079
`0.095
`0.118
`0.077
`0.097
`0.121
`0.121
`0.127
`0.145
`
`1.00
`15.46
`7.07
`4.37
`51.84
`1.22
`2.30
`12.96
`10.05
`1.62
`2.41
`2.32
`6.01
`
`12.317
`108.147
`36.859
`21.152
`260.206
`7.651
`19.265
`66.009
`70.204
`13.435
`20.793
`21.691
`58.331
`
`0.12
`1.05
`0.36
`0.20
`2.52
`0.07
`0.19
`0.64
`0.68
`0.13
`0.20
`0.21
`0.56
`
`Signal:
`
`2 DAD1 E, Sig=268,16 Ref=360,100
`
`Peak
`#
`
`RT
`{[min]
`
`Type Width Height
`{min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`4.12 BB
`1
`5.13 BB
`2
`5.63 BV
`3
`5.87 VP
`4
`7.91 BP
`5
`8.22 BB
`6
`9.96 BV
`7
`8 10.37 VB
`9 13.12 BB
`
`0.088
`0.085
`0.080
`0.078
`0.086
`0.084
`0.085
`0.079
`0.127
`
`1.62
`3.33
`15.60
`21.00
`1.75
`2.60
`2.21
`6.18
`2.76
`
`9.190
`17.950
`80.034
`107.740
`10.195
`15.164
`12.245
`31.036
`22.397
`
`3.00
`5.87
`26.16
`35.21
`3.33
`4.96
`4.00
`10.14
`7.32
`
`. 000000
`. 000000
`. 000000
`. 000000
`000000
`000000
`. 000000
`. 000000
`000000
`000000
`000000
`.000000
`000000
`
`. 000000
`. 000000
`182926
`000000
`. 000000
`000000
`000000
`. 000000
`000000
`
`*** End of Report ***
`
`L-224,715
`
`HPLCO157
`
`02/19/2002
`
`11:35:45 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 167
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 167
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\068-0101.D
`
`Sample Name: 70316-039
`
`5.07g/50m1l of 50.00g ml and wash
`
`->
`
`Injection Date : 02/19/2002
`Sample Name
`: 70316-039
`Acq Operator
`> hansen
`
`11:22:57 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1lmli/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`:
`:
`:
`:
`
`1
`68
`1
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (068-0101.D)
`
`4
`
`DAD1 E, Sig=268,16 Ref=360,100 (068-0101 D)
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DADI C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`1
`2
`3
`4
`5
`6
`7
`
`8
`9
`10
`11
`12
`13.
`14
`15
`
`2.43 VP
`3.15 BV
`4.12 BP
`5.13 BV
`5.28 VP
`5.63 BV
`5.87 VV
`
`6.19 VB
`7.62 BV
`7.90 VV
`8.06 VV
`8.22 VV
`8.50 VB
`8.87 BV
`9.05 VB
`
`184.439
`48.45
`0.058
`13.726
`2.32
`0.091
`29.849
`5.26
`0.088
`58.757
`10.91
`0.085
`8.590
`1.68
`0.077
`700.828
`0.080 136.26
`0.082 1.62e3 8255.455
`
`0.109
`0.110
`0.094
`0.053
`0.101
`0.101
`0.102
`0.073
`
`2.77
`5.79
`12.82
`1.56
`22.52
`3.56
`4.00
`1.26
`
`21.703
`45.499
`83.163
`5.439
`159.956
`25.411
`28.711
`5.976
`
`1.78
`0.13
`0.29
`0.57
`0.08
`6.78
`79.81
`
`0.21
`0.44
`0.80
`0.05
`1.55
`0.25
`0.28
`0.06
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.182926
`0.000000
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`ate
`ry
`
`HPLCO157
`
`02/19/2002
`
`11:35:45 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 168
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 168
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C:\HPCHEM\HPLC0157\DATA\068-0101.D
`Area
`Area
`RT
`Type Width Height
`{min]
`[min]
`
`{mAU*s]
`
`%
`
`Sample Name: 70316-039
`Name
`
`7.07 VB
`16
`7.45 BV
`17.
`7.63 VV
`18
`7.92 VV
`19
`8.11 VB
`20
`9.07 BV
`21
`9.22 VV
`22
`9.37 VV
`23.
`9.49 VV
`24
`9.71 VB
`25
`26 10.29 PB
`27 11.51 BV
`28 11.73 VV
`29 11.90 VP
`30 12.40 BV
`31 12.67 VV
`32 13.05 VB
`
`0.123
`0.138
`0.133
`0.150
`0.108
`0.093
`0.091
`0.089
`0.086
`0.090
`0.131
`0.114
`0.092
`0.118
`0.111
`0.095
`0.365
`
`0.84
`4.07
`3.48
`3.86
`1.57
`5.73
`1.81
`5.84
`4.01
`3.41
`1.46
`3.48
`3.42
`9.35
`1.16
`1.50
`2.72
`
`183.348
`39.146
`31.944
`42.976
`11.531
`34.086
`70.083
`34.695
`22.802
`247.354
`12.139
`26.805
`80.036
`78.452
`8.880
`9.658
`78.748
`
`1.52
`0.32
`0.26
`0.36
`0.10
`0.28
`0.58
`0.29
`0.19
`2.05
`0.10
`0.22
`0.66
`0.65
`Q.07
`0.08
`0.65
`
`Signal:
`
`2 DADI1 E, Sig=268,16
`
`Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`
`Area
`
`[mAU*s]
`
`%
`
`2.94 BP
`1
`3.18 VB
`2
`4.01 BB
`3
`4.45 BP
`4
`5.37 VB
`5
`0.00
`6
`6.73 VV
`7
`7.07 VB
`8
`9.22 BV
`9
`9.38 VP
`10
`9.71 VB
`ll
`12 11.73 BV
`13 13.06 PB
`
`0.122
`0.104
`0.163
`0.114
`0.086
`0.000
`0.096
`0.119
`0.110
`0.163
`0.087
`0.079
`0.256
`
`1.65
`1.38
`1.83
`6.97
`9.02
`0.00
`1.78
`2.57
`1.88
`1.11
`5.08
`1.02
`1.23
`
`14.471
`9.700
`21.120
`52.463
`104.015
`0.000
`11.865
`21.869
`14.103
`13.691
`28.500
`5.164
`22.646
`
`4.53
`3.03
`6.61
`16.41
`32.54
`0.00
`3.71
`6.84
`4.41
`4.28
`8.92
`1.62
`7.09
`
`. 000000
`. 000000
`. 000000
`000000
`000000
`000000
`000000
`. 000000
`000000
`. 000000
`.000000
`.000000
`000000
`. 000000
`.000000
`000000
`000000
`
`.000000
`. 000000
`. 000000
`. 000000
`-000000
`. 000000
`.000000
`. 000000
`000000
`.000000
`000000
`. 000000
`. 000000
`
`*** End of Report ***
`
`L-224,715
`
`HPLCO157
`
`02/19/2002
`
`10:59:38 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 169
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 169
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLC0157\DATA\062-0101.D
`
`Sample Name: 70316-0%94
`
`EDC coupling lh at 0 C
`
`->
`
`Injection Date : 02/13/2002
`Sample Name
`: 70316-035
`Acq Operator
`>: hansen
`
`8:29:32 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`> C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile,
`Iml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`:
`>:
`:
`:
`
`1
`62
`1
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (062-0101 D)
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`{min]
`
`Type Width Height
`[min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.16 BV
`1
`2.28 VV
`2
`2.44 VV
`3.
`2.58 VB
`4
`0.00
`5
`8.59 BP
`6
`9.38 PP
`7
`9.89 BP
`8
`9 11.54 BV
`10 11.91 VV
`11 12.08 VB
`
`13.010
`3.18
`0.062
`0.060 382.63 1520.607
`0.061 116.66
`449.003
`0.088
`20.46
`125.811
`0.000
`0.00
`0.000
`0.080
`2.81
`14.814
`0.104
`1.14
`8.628
`0.093
`2.61
`15.884
`0.110
`1.03
`7.976
`0.077
`55.68
`273.914
`0.081 1.10e3 5609.710
`
`0.16
`18.91
`5.59
`1.56
`0.00
`0.18
`0.11
`0.20
`0.10
`3.41
`69.78
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`02/13/2002
`
`8:42:47 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 170
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 170
`Mylan v. Merck, IPR2020-00040
`
`
`
`:C:\HPCHEM\HPLC0157\DATA\062-0101.D
`Data file
`Signal:
`2 DAD1 E, Sig=268,16 Ref=360,100
`
`Sample Name: 70316-038 44
`,
`
`Peak
`#
`
`RT
`{(min]
`
`Type Width Height
`{min]
`
`Area
`(mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`0.00
`1
`211.91 BV
`3.12.08 VB
`
`0.000
`0.077
`0.079
`
`0.00
`7.27
`92.24
`
`0.000
`35.742
`465.031
`
`0.00
`7.14
`92.86
`
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`*** End of Report ***
`
`HPLCO157
`
`02/13/2002
`
`8:42:47 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 171
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 171
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C: \HPCHEM\HPLC0157\DATA\063-0101.D
`
`Sample Name: 70316-035
`
`EDC coupling 2.75h at 0 C
`
`Injection Date
`Name
`Sample
`Acq Operator
`
`02/13/2002
`70316-035
`hansen
`
`10:16:15 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`Method
`C: \HPCHEM\HPLCO157\METHODS\715.M
`01/14/2002
`1:00:57 PM
`:
`Last Changed
`lml/min
`75/25 0.1% HC104/Acetonitrile,
`75/25 from 10 to 14 min
`lOmin 25/75 water/acn;
`waters
`cl8 symmetry, 250 nm
`
`DAD1 C, Sig=210,8 Ref=360,100 (063-0101.D)
`
`4
`2
`0
`DAD1 E, Sig=268,16 Ref=360,100 (063-0101.D)
`
`
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`Signal
`01/14/2002
`1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`{min}
`
`Type Width Height
`{min]
`
`Area
`[mAU*s]}
`
`Area
`%
`
`Amount
`mg/ml
`
`2.16 BV
`1
`2.27 VV
`2
`2.44 VWV
`3.
`2.58 VB
`4
`0.00
`5
`7.02 BB
`6
`8.60 BP
`7
`9.38 BB
`8
`9.90 BP
`9
`10 11.54 BV
`11 °11.91 VV
`12 12.09 VB
`13 12.78 PB
`
`13.452
`2.98
`0.067
`0.063 502.58 2004.184
`0.061 144.18
`561.382
`0.075
`94.13
`473.539
`0.000
`0.00
`0.000
`0.093
`3.42
`22.671
`0.086
`3.72
`21.564
`0.117
`1.57
`13.351
`0.089
`3.17
`18.353
`0.086
`1.16
`6.516
`0.074
`2.36
`10.846
`0.080 1.36e3 6971.021
`0.204
`8.22
`111.157
`
`0.13
`19.60
`5.49
`4.63
`0.00
`0.22
`0.21
`0.13
`0.18
`0.06
`0.11
`68.16
`1.09
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`02/13/2002
`
`10:29:30 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 172
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 172
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\065-0101.D
`
`‘Sample Name: 70316-039
`
`0.3990gt/50ml of 74.83g methanol filtrate
`
`->
`
`Injection Date : 02/14/2002
`Sample Name
`: 70316-0039
`Acq Operator
`>: hansen
`
`9:58:33 AM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile,
`Iml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`1
`:
`: 65
`:
`1
`:
`2 pl
`
`‘
`
`DAD1 C, Sig=210,8 Ref=360, 100 (065-0101.D)
`
`0
`
`2
`
`4
`
`DAD1 E, Sig=268,16 Ref=360,100 (065-0101.D)
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 01/14/2002
`: 1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`{min}
`
`Type Width Height
`{[min]
`
`Area
`(mAU* s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`2.43 BB
`1
`5.15 BV
`2
`5.65 BV
`3.
`5.88 VB
`4
`8.25 BP
`5
`6 10.38 BB
`7:12.08 PB
`8 12.94 BB
`
`12.246
`3.25
`0.058
`8.051
`1.41
`0.089
`0.081 269.11 1411.016
`0.078 136.67
`676.410
`0.090
`2.33
`14.869
`0.083
`3.87
`20.999
`0.101
`1.09
`7.926
`0.089
`22.77
`127.373
`
`0.54
`0.35
`61.92
`29.68
`0.65
`0.92
`0.35
`5.59
`
`0.000000
`0.000000
`0.371556
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO0157
`
`02/14/2002
`
`10:11:45 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 173
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 173
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\064-0101.D
`
`Sample Name: 70316-0039
`
`hydrog after 18h 50C, 40PSI
`
`-?
`
`9:33:56 AM
`
`Injection Date : 02/14/2002
`Sample Name
`> 70316-039
`Acq Operator
`: hansen
`
`Seq Line
`Vial No
`Inj. No
`Inj. Vol.
`; C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 01/14/2002
`1:00:57 PM
`Last Changed
`75/25 0.1% HC104/Acetonitrile,
`iml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl8 symmetry, 250 nm
`
`1
`64
`1
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (064-0101.D)
`
`qj 3
`its
`
`B
`noo &
`Q
`Ros
`$8
`38
`IK
`8
`gs
`= es
`a 7
`no
`ws
`N,
`?
`bein fpel
`
`4
`2
`0
`DAD1 E, Sig=268,16 Ref=360,100 (064-0101.D)
`
`6
`
`8
`
`10
`
`12
`
`14
`
`mi
`
`¢©
`©
`
`@
`
`tS
`
`mAU
`600
`500
`400
`300
`200
`100
`0
`
`mAU
`
`600
`500
`
`400
`
`300
`200
`
`
`
`0
`
`0
`
`9a
`
`2
`
`4
`6
`8
`10
`
`
`12
`
`14
`
`mi
`
`Customized Report:karlo
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`Signal
`01/14/2002
`1.000000
`
`1:00:30 PM
`
`Signal:
`
`1 DAD1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`[min]
`
`Area
`[mAU*s]
`
`Area
`
`Amount
`mg/ml
`
`Name
`
`2.17 BV
`1
`2.43 VB
`2
`3.14 BB
`3
`5.15 BV
`4
`5.31 VP
`5
`5.64 BV
`6
`5.89 VB
`7
`6.22 BB
`8
`7.94 PV
`9
`8.26 VV
`10
`8.52 VB
`11
`9.91 PV
`12
`13 10.11 VV
`14 10.40 VP
`15 11.70 BV
`
`5.278
`1.33
`0.060
`70.466
`19.89
`0.055
`9.055
`1.27
`0.111
`45.540
`8.07
`0.088
`11.385
`2.18
`0.079
`0.088 1.36e3 7478.898
`0.078 779.93 3891.804
`0.113
`1.21
`9.728
`0.088
`5.18
`31.008
`0.099
`14.25
`99.158
`0.086
`1.35
`7.644
`0.081
`2.68
`14.072
`0.079
`1.91
`9.602
`0.079
`20.55
`104.739
`0.091
`1.16
`7.237
`
`0.04
`0.55
`0.07
`0.36
`0.09
`58.36
`30.37
`0.08
`0.24
`0.77
`0.06
`0.11
`0.07
`0.82
`0.06
`
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`1.983213
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`0.000000
`
`L-224,715
`
`HPLCO157
`
`02/14/2002
`
`9:47:07 AM
`
`Page 1 of 2
`Merck Exhibit 2129, Page 174
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 174
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`Peak
`#
`
`:C: \HPCHEM\HPLCO157\DATA\064-0101.D
`Area
`Area
`RT
`Type Width Height
`[min]
`([min]
`
`[mAU*s]
`
`%
`
`Sample Name: 70316-039
`Name
`
`16 11.93 VV
`17 12.10 VV
`18 12.18 VB
`19 12.46 BV
`20 12.95 VB
`
`1.74
`0.118
`5.87
`0.080
`4.10
`0.074
`1.40
`0.106
`0.096 148.23
`
`14.323
`31.169
`21.077
`10.325
`942.241
`
`0.11
`0.24
`0.16
`0.08
`7.35
`
`. 000000
`000000
`. 000000
`000000
`000000
`
`Signal:
`
`2 DAD1 E, Sig=268,16
`
`Ref=360,100
`
`Peak
`#
`
`RT
`{[min]
`
`Type Width Height
`[min]
`
`Area
`
`Area
`
`[mAU*s]
`
`%
`
`5.16 BB
`1
`5.64 BV
`2
`5.89 VB
`3
`8.26 BB
`4
`5 10.40 PP
`6 12.96 BB
`
`2.07
`0.088
`0.082 171.21
`0.080
`9.45
`0.099
`1.83
`0.077
`2.42
`0.098
`3.36
`
`11.680
`
`15
`
`000000
`. 983213
`000000
`000000
`000000
`000000
`
`L-224,715
`
`*** End of Report ***
`
`HPLCO157
`
`02/14/2002
`
`9:47:07 AM
`
`Page 2 of 2
`Merck Exhibit 2129, Page 175
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 175
`Mylan v. Merck, IPR2020-00040
`
`
`
`ProjectNo.___-_— Project Page
`> 4Y °
`Page
`7031 6
`Book
`DateASFb2082|Investigator
`oO
`(iu A Race aalt
`BASate
`
`Subject
`
`Filed in Book Number/Title
`
`Fo
`
`6
`is
`L
`\ Cevw
`|
`King rts:
`p
`A ndoot eA
`Jpnael,
`C
`
`.
`Al
`* wre N ERCabn LRaAIT(E -PMesplotc
`1 Pe X
`Fu
`A+ pAL|
`337A
`2
`Od
`22.0
`47
`[1,71
`I$.¢
`
`Pert
`
`dd
`360
`
`+
`1.0
`Lo
`[
`
`ay
`12324- [pF
`2\F4 -
`
`Joo
`
`620
`
`JO}. 1S
`
`12.45
`
`|
`|
`"
`
`Qe, Mel PIE
`Mn
`u2—\
`_ACN
`cath tu<«
`footy Act A
`Prtt VDess.lod
`HCl Cold clay
`Res of Trsrel
`AMSA 42~1 KON tte
`& fri
`aed,
`Mm
`Lok.
`AddeA EdC
`MEly lok
`9 96 cw FAA ved
`Atla Qo whe SBorletelc, Cot wba ef]
`oS) Mala
`~4{{
`oat SaMh cl 2O—-Y
`a
`cathe! Cornporhnts + o
`
`AAGrHyder,oh. methanel J2slorPa[e WPSt He
`
`=
`allu® Bro cleaud. Gl hed oFF
`Ae o9
`~~
`ft
`uc
`(,<+ duykA UK| Mcp
`A-
`2
`Ci bet ‘
`b Cante
`Cal
`ul
`(FV.
`ect
`L224 1s.
`A fs oe,
`SH.
`ld
`4 Re-digsluck
`yp a thast
`(acaba AK.
`Ke dedsalost
`12 St Ett 40(hcA eteBnk VBP.
`wotdl Flese Fm SER tale (EbyA I
`(5 $03
`24. Poy
`(Los en
`. GAS
`O
`i
`sth L
`{
`ha of 4
`3
`—fLE——__ 2) Rb awe
`
`i
`
`f\
`
`fA
`
`4
`
`La
`
`A
`
`nN
`
`Countersigned by ~
`
`:
`Merck Exhibit 2129, FACRCNR
`Mylan v. Merck, IPR2020600064000) NCMPL =
`
`Date
`
`Merck Exhibit 2129, Page 176
`Mylan v. Merck, IPR2020-00040
`
`
`
`Book
`
`7031 6
`
`Page
`
`4?
`
`Project No... _sCéPrroject Page
`
`52
`
`. DO NOT BEGIN NEW EXPERIMENTS ON THIS PAGE.
`
`| Fibacs2
`AAdcd
`‘JO [.-O35
`ae Ay
`|
`ooh d
`ALA GSm1 End 4
`sha
`©
`Vie
`le
`hen,
`TheA—
`
`i
`
`ro,
`lade
`hot
`weshJ
`
`OLane Gon
`
`3
`
`.
`5 fo|
`Miro s&pe
`ir
`RT
`(alu
`Do | ENA).
`
`oh.
`
`'H
`
`ak
`
`AoW No eThSA.
`A} AA,
`TLinmes =
`6934
`
`G2n,
`
`siesu/
`
`che $5 W
`(\ 0 Iu—-0
`
`ow Thal rt eatin
`1
`S pps
`Ih
`g an
`
`wv dre Dies at
`
`S26 ks lis \ [LA
`
`Yao).
`
`ref
`
`qc é
`
`ASVYL
`
`a
`
`re
`
`|fllllIlllilllliI|ll
`
`|llllkllttlt|ll
`
`_—
`
`Date
`Merck Exhibit 2129, Page 177
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 177
`Mylan v. Merck, IPR2020-00040
`
`
`
`SOLUTION
`a TITRATION a c
`
`
`
`
`
`ANALYSIS PSA | DSC : a TG | X-RAY|| TLC | ‘ BULK |_| . MESH || ALL
`
`
`
`ao
`
`aad
`MERCK & CO., INC’.
`R827-L 4/755
`A
`DATE
`=
`°
`Ceo Ue?
`
`SUBMITTED BY
`\S
`
`Ser (4.
`POS
`
`VUSAS
`
`OMPLETE STRUCTURE
`
`.
`
`-
`to
`*
`PPCL #
`23061
`SAMPLE DISPOSITION
`
`*
`
`cet YP ntYT RN we oe SO
` _ a
`TAias so,
`REQUEST FOR ANALYSIS ‘ _
`+
`NOTEBOOK OR BATCH #
`PROJECT #
`[0816 - Ox
`MOLECULAR WEIGHT
`
`:
`
`SEND REPORT TO
`
`7 7
`
`.
`
`ExT
`Cos
`AREA
`
`{ IRETAIN[ JRETURN[ JDISCARO
`
`°
`
`CHEMICAL NAME
`
`ease TOWN be
`C-V24UT 3004 Recomm
`
`,
`
`EMPIRICAL FORMULA
`
`OTHER TESTS AND COMMENTS
`
`test
`
`SOLIDS
`
`-
`
`UV
`
` SPECIFIC
`
`ROTATION
`
`
`IGNITION
`
`|] psehta LJ some
`LOSS ON
`
`
`DRYING
`
`
`
`
`‘
`
`Cc
`
`Ceeeeeaden
`
`
`ANALYSIS
`
`CONTROLS
`
`CHN
`
`ve
`
`DO
`NOT
`WRITE
`BELOW
`THIS
`LINE
`
`RESULTS
`
`ao CORD
`
`Chava
`
`
`4
`
`;
`
`C- 4D, TUN - 44,42 2%
`L- UNS - Sd.08
`
`HQ & wZIy-ir]
`
`Lan
`Avcatte
`
`.
`OA
`OAS
`
`ON “te
`
`005 %
`
`Oo®)
`
`1.08
`
`ON
`
`44.66%
`
`O44L
`
` PP LAB PROC. #
`
`ANALYST
`
`Merck Exhibit 2129, Page 178
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 178
`Mylan v. Merck, IPR2020-00040
`
`
`
`2002022054.001
`
`2/20/02
`
`- 2/21/02
`
`HYDROGENATION OR HIGH PRESSURE REACTION
`
`QIAISY. |
`
`r
`o
`-
`i
`-
`
`
`DUESTED BY Hani BLDG/RM EXT. _) DATEwirbr&*f aG !
`wae
`a
`.
`j
`
`prosectno___*?7//*_provect M ‘2 7h NOTEBOOK- PAGE NO__:’_ 2 fs -
`
`
`“¢/
`
`CHECK HEREIF REACTION IS GMP/GLP 0—STARTINGMATERIAL
`
`NO. 1
`
`MW, | «. an W. AMOUNT_______ G._ MOLES
`
`STRUCTURAL FORMULA:
`
`CATALYsT___-+ CG.
`SOLVENT
`MOLES OF HYDROGEN REQUIRED
`OTHER MATERIALS
`ttl,
`a!
`coe
`REACTION CONDITIONS, ETC.
`{ov ,.
`
`TF,
`
`PRECAUTIONS:
`
`et iC
`,
`ia
`
`_| | Ale
`
`TEMP.
`
`DROP
`
`EMPIRICAL FORMULA:
`SSSSSSSSSSESSSSSSSSESESSSS -
`
`TO BE FILLED IN BY HYDROGENATION LABORATORY
`NotOY moes 42.0/24/ nog,i. eS
`catayst._2. or YK AHI
`Jn le POIs
`
`IPoM
`SOLVENT. LOO
`
`OTHER MATERIALS
`
`
`CELL NO_____ HEATER NO REC. POINT INTERNAL _____ EXTERNAL________ BOMB NO________vesseLsize__~“27ML.
`SHAKER no“/uinen —__ SHAKER TANK —__/7/7 AUX. TANK ______ SYSTEM VOLUME__7ssML.
`C'DH, PRESSURE DROP=— ves.mo.e <2£011__ motes= L274 Las.
`
`DITIONS______ HRS. AT_.22_ CC. MISC. DATA: a
` <=
`
`Ser=|OROF
`
`P.
`
`T
`
`eRNEOAme
`
`RUNBY, }Jonas pateLoi, Qo oor.
`
`DATE
`RUN BY
`Merck Exhibit 2129, Page 179
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 179
`Mylan v. Merck, IPR2020-00040
`
`€
`
`
`ShkiS4 Product Temp
`
`Hist.FIX.PT5407.F_CV
`Hist.FIX.DTS409.F_CV
`ist.F1X.TES403.F_CV
`
`43:39:19
`2/20/02
`
`Shkr54 Pressr
`ShkrS4 H2 Uptake
`
`2002022054.001
`
`Merck Exhibit 2129, Page 180
`Mylan v. Merck, IPR2020-00040
`
`Merck Exhibit 2129, Page 180
`Mylan v. Merck, IPR2020-00040
`
`
`
`Data file
`
`:C:\HPCHEM\HPLCO157\DATA\083-0101.D
`
`Sample Name: 70316-041
`
`12.50g/100m1l of 66.25 g ML's
`
`->
`
`Injection Date : 02/21/2002
`Sample Name
`> 70316-041
`Acq Operator
`: hansen
`
`2:00:19 PM
`
`Seq Line
`Vial No
`Inj. No.
`Inj. Vol.
`: C:\HPCHEM\HPLCO157\METHODS\715.M
`Method
`: 02/21/2002
`7:13:49 AM
`Last Changed
`75/25 0.1% HC104/Acetonitrile, 1ml/min
`10min 25/75 water/acn; 75/25 from 10 to 14 min
`waters cl18 symmetry, 250 nm
`
`1
`:
`: 83
`:
`1
`:
`2 pl
`
`DAD1 C, Sig=210,8 Ref=360,100 (083-0101.D)
`
`:
`
`DAD1 E, Sig=268,16 Ref=360,100 (083-0101.D)
`
`Sorted By
`Calib. Data Modified
`Multiplier
`
`: Signal
`: 02/20/2002
`: 1.000000
`
`3:33:04 PM
`
`Signal:
`
`1 DADI1 C, Sig=210,8 Ref=360,100
`
`Peak
`#
`
`RT
`[min]
`
`Type Width Height
`{min]
`
`Area
`[mAU*s]
`
`Area
`%
`
`Amount
`mg/ml
`
`Name
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13.
`14
`15
`
`2.43 VB
`3.64 PB
`4.14 PP
`5.17 VP
`5.66 BV
`5.88 VB
`7.64 BV
`7.74 VV
`7.90 VV
`8.08 VV
`8.23 VV
`8.51 VV
`8.89 VV
`9.05 VB
`9.97 PV
`
`135.757
`35.38
`0.059
`540.202
`0.080 105.11
`11.908
`0.085
`2.19
`113.330
`0.084
`20.69
`451.690
`0.097
`71.88
`0.088 2.02e3 1.106e4
`20.081
`2.46
`0.117
`0.072
`4.15
`20.054
`0.111
`14.58
`118.1
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
